JOHN ALDRIDGE: Open Payments
NPI 1902150089 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 8 payments from 7 companies in 2025. Trend: 2023 $485 · 2024 $321 · 2025 $154
Food & beverage: $139Education: $15
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $43 |
| Amgen Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
Products named: VIVITROL, KRYSTEXXA, Kerendia, UBRELVY, CAPLYTA, Wegovy, BRIXADI.
Industry payments across AL — which companies pay providers there.
